Key result
Calcium release deficiency syndrome emerges as a RyR2 loss-of-function ryanodinopathy distinct from classical CPVT.
Why the study?
Calcium release deficiency syndrome (CRDS) fundamentally differs from classical CPVT, necessitating distinct approaches to its diagnosis, clinical management, and therapeutic intervention.
Answers are grounded in this paper and cite their sources.
CRDS is an emerging ryanodinopathy caused by loss-of-function mutations in RyR2, requiring distinct diagnostic and therapeutic approaches from classical CPVT.
The cardiac ryanodine receptor (RyR2) is a critical calcium release channel essential for normal cardiac contraction. Dysregulation of RyR2 function is a key pathogenic factor in various cardiac diseases, notably arrhythmias and heart failure. The clinical spectrum of RyR2-related diseases (ryanodinopathy) has expanded beyond the well-established gain-of-function (GOF) mutations causing catecholaminergic polymorphic ventricular tachycardia (CPVT). Recent research has now delineated two additional distinct clinical entities: exon 3 deletion syndrome (E3DS), which presents with CPVT along with structural abnormalities, and calcium release deficiency syndrome (CRDS), caused by loss-of-function (LOF) mutations. CRDS is characterized by impaired calcium release from the sarcoplasmic reticulum and fundamentally differs from the classical CPVT phenotype, necessitating distinct approaches to its diagnosis, clinical management, and therapeutic intervention. This review provides a comprehensive overview of the current understanding of CRDS. We discuss its clinical manifestations, scrutinize the underlying molecular mechanisms, evaluate available diagnostic strategies, and explore potential therapeutic avenues. By synthesizing latest findings, this review aims to illuminate the complexities of RyR2-mediated pathologies and foster further progress in this evolving field.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) conducted a review in Calcium release deficiency syndrome (CRDS). Calcium release deficiency syndrome is an emerging ryanodinopathy caused by loss-of-function mutations in the RyR2 gene, characterized by impaired calcium release and distinct from classical CPVT.
Synapse has enriched 10 related papers. Consider them for comparative context: